Effect of hormone replacement and selective estrogen receptor modulators (SERMs) on the biomechanics and biochemistry of pelvic support ligaments in the cynomolgus monkey (Macaca fascicularis)

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 5, 2010, Pages 485.e1-485.e9

  Shahryarinejad, Azin ^a   Gardner, Thomas R ^b   Cline, J Mark ^c   Levine, William N ^b   Bunting, Haley A ^b   Brodman, Michael D ^d   Ascher Walsh, Charles J ^d   Scotti, Richard J ^a   Vardy, Michael D ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

macaca fascicularis; pelvic organ prolapse; round ligament; SERMs; uterosacral ligament

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; ETHINYLESTRADIOL; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BIOMECHANICS; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG EFFICACY; FEMALE; FUNCTION TEST; HORMONE ACTION; HORMONE SUBSTITUTION; LIGAMENT; MACACA; MENOPAUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RIGIDITY; STEP STRAIN TESTING; TENSILE STRENGTH; UTERUS;

EID: 77951828297     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.01.074     Document Type: Article

References (43)

1. DeLancey J.O.L. The anatomy of the pelvic floor. Curr Opin Obstet Gynecol 6 (1994) 313-316
2. Norton P.A. Pelvic floor disorders: the role of fascia and ligaments. Clin Obstet Gynecol 36 (1993) 926-938
3. Chen G.D., Oliver R.H., Leung B.S., Lin L.Y., and Yeh J. Estrogen receptor alpha and beta expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women. Fertil Steril 71 (1999) 1099-1102
4. Mokrzycki M.L., Mittal K., Smilen S.W., Blechman A.N., Porges R.F., and Demopolous R.I. Estrogen and progesterone receptors in the uterosacral ligament. Obstet Gynecol 90 (1997) 402-404
5. Goh J.T.W. Biomechanical properties of prolapsed vaginal tissue in pre and post menopausal women. Int Urogynecol J 13 (2002) 76-79
6. Reay-Jones N.H., Healy J.C., King L.J., Saini S., Shousha S., and Allen-Mersh T.G. Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse. Br J Surg 90 (2003) 466-472
7. Kökçü A., Yanik F., Çetinkaya M., Alper T., Kandemir B., and Malatyalioglu B. Histopathological evaluation of the connective tissue of the vaginal fascia and the uterine ligaments in women with and without pelvic relaxation. Arch Gynecol Obstet 266 (2002) 75-78
8. Goh J.T.W. Biochemical and biochemical assessments for pelvic organ prolapse. Curr Opin Obstet Gynecol 15 (2003) 391-394
9. Kim C.M., Jeon M.J., Chung D.J., Kim S.K., Kim J.W., and Bai S.W. Risk factors for pelvic organ prolapsed. Int J Gynecol Obstet 98 (2007) 248-251
10. Brown J.S., Grady D., Ouslander J.G., Herzog A.R., Varner R.E., and Posner S.F. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 94 (1999) 66-70
11. Akizuki S., Mow V.C., Müller F., Pita J.C., Howell D.S., and Manicourt D.H. Tensile properties of human knee joint cartilage: I, influence of ionic conditions, weight bearing, and fibrillation on the tensile modulus. J Orthop Res 4 (1986) 379-392
12. Rasanen T., and Messner K. Estrogen-dependent tensile properties of the rabbit knee medial collateral ligament. Scand J Med Sci Sports 10 (2000) 20-27
13. Vardy M.D., Gardner T.R., Cosman F., et al. The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model. Am J Obstet Gynecol 192 (2005) 1741-1751
14. Haas J.S., Kaplan C.P., Gerstenberger E.P., and Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 140 (2004) 184-188
15. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 288 (2002) 321-333
16. Majumdar S.R., Almasi E.A., and Stafford R.S. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA 292 (2004) 1983-1988
17. Hersh A.L., Stefanick M.L., and Stafford R.S. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291 (2004) 47-53
18. Hing E., and Brett K.M. Changes in US prescribing patterns of menopausal hormone therapy, 2001-2003. Obstet Gynecol 108 (2006) 33-40
19. Hendrix S.L., and McNeeley S.G. Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium. Ann N Y Acad Sci 949 (2001) 243-250
20. Cauley J.A., Norton L., Lippman M.E., et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial-multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat 67 (2001) 191-199
21. Vogel V.G., Costantino J.P., Wickerham D.L., et al., National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295 (2006) 2727-2741
22. Silfen S.L., Ciaccia A.V., and Bryant H.U. Selective estrogen receptor modulators: tissue selectivity and differential uterine effects. Climacteric 2 (1999) 268-283
23. Vardy M.D., Lindsay R., Scotti R.J., et al. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 189 (2003) 81-88
24. Goldstein S.R., and Nanavati N. Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol 187 (2002) 521-527
25. Warming L., Christoffersen C., Riis B.J., Stakkestad J.A., Delmas P.D., and Christiansen C. Adverse effects of a SERM (Levormeloxifene): safety parameters and bone mineral density 12 months after treatment withdrawal. Maturitas 44 (2003) 189-199
26. Goldstein S.R., Neven P., Zhou L., Taylor Y.L., Ciaccia A.V., and Plouffe L. Raloxifene effect on frequency of surgery for pelvic floor relaxation. Obstet Gynecol 98 (2001) 91-96
27. Sharma S., Albertazzi P., and Bottazzi M. The long-term effect of raloxifene on the genitourinary tract. Climacteric 10 (2007) 244-248
28. Albertazzi P., and Sharma S. Urogenital effects of selective estrogen receptor modulators: a systematic review. Climacteric 8 (2005) 214-220
29. Cline J.M., Register T.C., and Clarkson T.B. Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys. Menopause 9 (2002) 242-252
30. Cline J.M., Söderqvist G., Register T.C., Williams J.K., Adams M.R., and Von Schoultz B. Assessment of hormonally active agents in the reproductive tract of female nonhuman primates. Toxicol Pathol 29 (2001) 84-90
31. Sikoski P., Register T.C., Lees C.J., et al. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaque fascicularis). Am J Obstet Gynecol 196 (2007) 75-77
32. Otto L.N., Slayden O.D., Clark A.L., and Brenner R.M. The rhesus macaque as an animal model for pelvic organ prolapse. Am J Obstet Gynecol 186 (2002) 416-421
33. Shahryarinejad A., and Vardy M.D. Comparison of human to macaque uterosacral-cardinal ligament complex and its relationship to pelvic organ prolapse. Toxicol Pathol 6 suppl 1 (2008) 101S-107S
34. Ulfelder H. The mechanism of pelvic support in women: deductions from a study of the comparative anatomy and physiology of the structures involved. Am J Obstet Gynecol 72 (1956) 856-864
35. Weber A.M., Buchsbaum G.M., Chen B., et al. Basic science and translational research in female pelvic floor disorders: proceedings of an NIH-sponsored meeting. Neurourol Urodyn 23 (2004) 288-301
36. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31 (2003) 3406-3415
37. Woo S.L., Gomez M.A., and Akeson W.H. The time and history-dependent viscoelastic properties of the canine medical collateral ligament. J Biomech Eng 103 (1981) 293-298
38. Abramowitch S.D., Feola A., Jallah Z., and Moalli P.A. Tissue mechanics, animal models, and pelvic organ prolapse: a review. Eur J Obstet Gynecol Reprod Biol 144 Suppl 1 (2009) S146-S158
39. Doillon C.H., Dunn M.G., Bender E., and Silver F.H. Collagen fiber formation in repair tissue: development of strength and toughness. Coll Relat Res 5 (1985) 481-492
40. Niyibizi C., and Eyre D.R. Structural characteristics of cross-linking sites in type V collagen of bone: chain specificities and heterotypic links to type I collagen. Eur J Biochem 224 (1994) 943-950
41. Liapis A., Bakas P., Pafiti A., et al. Changes of collagen type III in female patients with genuine stress incontinence and pelvic organ prolapse. Eur J Obstet Gynecol 97 (2001) 76-79
42. Alperin M., and Moalli P.A. Remodeling of vaginal connective tissue in patients with POP. Curr Opin Obstet Gynecol 18 (2006) 544-550
43. Chen B.H., Wen Y., Li H., and Polan M.L. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic organ prolapse. Int Urogynecol J 13 (2002) 80-87